Skip to Main Content

Insight

August 2024
Cannabis and Psychedelics Monthly Newsletter

the buzz: Cannabis News & Policy Update | August 2024

By Rachel Gillette and Jennifer Benda

Welcome to the buzz, our monthly cannabis news and policy update. Your at-a-glance source for regulatory developments, agency announcements, and trends impacting the cannabis industry.

This month's highlights include:

  • IRS Counsel Luke Ortner’s commentary on 280E at the AICPA & CIMA Cannabis Industry Conference
  • Federal Rescheduling: summary of public comments and next steps
  • New licensing opportunities in Delaware, Kentucky, Minnesota, and Missouri
  • Regulatory developments in Oregon, Colorado, and New York
  • Hemp regulations and litigation, including recent state enforcement aimed at hemp-derived THC products

Read Here

This publication is designed to provide general information on pertinent legal topics. The statements made are provided for educational purposes only. They do not constitute legal or financial advice nor do they necessarily reflect the views of Holland & Hart LLP or any of its attorneys other than the author(s). This publication is not intended to create an attorney-client relationship between you and Holland & Hart LLP. Substantive changes in the law subsequent to the date of this publication might affect the analysis or commentary. Similarly, the analysis may differ depending on the jurisdiction or circumstances. If you have specific questions as to the application of the law to your activities, you should seek the advice of your legal counsel.

DISCLAIMER

Unless you are a current client of Holland & Hart LLP, please do not send any confidential information by email. If you are not a current client and send an email to an individual at Holland & Hart LLP, you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us, unless we have already agreed to represent you or we later agree to do so. Thus, we may represent a party adverse to you, even if the information you submit to us could be used against you in a matter, and even if you submitted it in a good faith effort to retain us.

Accept